|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Apoptosis 2003 - From signaling pathways to therapeutic tools. | ||||||||||||||||
| November 12, 2002 | ||||||||||||||||
|
RCMS, Luxembourg 29 january 2003 Scientific program Wednesday January 29th, 2003 Afternoon Keynote talk Stanley Korsmeyer (Harvard Medical School, Boston, USA) Oral Session 1 : Cell death and development Michael O. Hengartner (University of Zurich) : The nematode C. elegans as a model system to study engulfment Sara C. Ahlgren (California Institute of Technology) : Apoptotic signaling molecules during neural crest development Pierre Golstein (Centre d'Immunologie de Marseille-Luminy, France) : Cell death in Dictyostelium discoideum Kate Hardy (Imperial College, London, UK) : Cell death during human preimplantation embryo development Jean-Claude Ameisen (EMI-U 9922 INSERM/Universite Paris 7, France) : On the origin, evolution and nature of programmed cell death Thursday January 30, 2003 Morning Oral Session 2A : Mitochondria as regulators of apoptosis Guido Kroemer (Institut Gustave Roussy, France) : Essential role of the mitochondrial membrane permeabillization in programmed cell death Andreas Strasser (The Walter and Eliza Hall Institute, Victoria, Australia) : Bcl-2 family in cell-death control. Philippe Bouillet (The Walter and Eliza Hall Institute, Victoria, Australia) : Bim and related proteins Jean-Claude Martinou (University of Geneva, Switzerland) : Bid and Bax Oral Session 2B : Apoptotic signal transduction pathways Roger Davis (Worcester, Massachusetts) : Role of kinases in apoptotic signal transduction. Helen Beere (La Jolla, USA) : Stressed to death: regulation of apoptotic signaling pathways by the heat shock proteins Jakob Troppmair (University of Wuerzburg) : Apoptosis suppression by Raf: novel connections Thomas J. Povsic (Duke University Medical Centre, Durham, USA) : beta-arrestins and apoptotic signalling Oral Session 2C : Satellite Meeting I Abraham Amsterdam (Weizman Institute of Science, Revohot, Israel) : Novel genes modulated by gonadotropins: new perspectives in the control of ovarian cell death Hakan Billig (Department of Physiology, Goteborg, Sweden) : Progesterone receptor mediated regulation of apoptosis in ovarian cells John Peluso (University of Connecticut Health Centre, USA) : Basic Fibroblast growth factor regulation of granulosa cell apoptosis Atan Gross (Department of Biological Regulation, Revohot, Israel) : Exploring the role of caspases in determining the fate of ovarian follicles Thursday January 30, 2003 Morning Oral Session 3A : Inhibitors and activators of apoptosis Stephen Prescott (University of Utah, USA) : Intracellular unesterified arachidonic acid signals apoptosis Masataka Mori (Kumamoto University School of Medicine) : Nitric Oxide- and ER Stress-mediated Apoptosis Young-Joon Surh (Seoul National University) : Chemopreventive Dietary and Medicinal Phytochemicals and cell death Craig Thompson (University of Pennsylvania School of Medicine) Bcl-XL and inositol 1,4,5-trisphosphate receptors Oral Session 3B : Receptors as cell death mediators Bharat Aggrawal (Anderson Cancer Centre) : Regulation of Proliferation, Survival and Apoposis by Members of the TNF Superfamily Peter H. Krammer : (German Cancer Research Centre, Heidelberg) : CD95(APO-1/Fas) signaling: the role of FLIP. Ulf R. Rapp (University of Wuerzburg) : Neurotrophin Receptor-interacting Mage Homologue Is an Inducible Inhibitor of Apoptosis Protein-interacting Protein That Augments Cell Death Rudi Beyaert (University of Ghent, Belgium) : Cross-talk between NF-kB activating and apoptosis-inducing signalling proteins Oral Session 3C : Apoptosis in human pathologies Thomas Mandrup-Poulsen (Steno Diabetes Centre, Denmark) : Apoptotic signal transduction pathways in diabetes Decio L. Eizirik (ULB, Belgium) : Microarray analysis of apoptosis in pancreatic beta-cells Oral Session 3D : Satellite I Friday January 31, 2003 Morning Oral Session 4A : Caspases : Jurg Tschopp (University of Lausanne, Switzerland) : Control of caspase activation by FLIP and ASC Klaus Schulze-Osthoff (University of Münster, Germany) : Caspases: more than just killers ? Seamus Martin (Trinity College, Ireland) : Ordering caspase activation events in apoptosis Oral Session 4B : Transcriptional and post-transcriptional regulation of apoptosis J. Don Chen (Department of Biochemistry and Mol. Pharmacology, Worcester, MA, USA) : Steroid/nuclear hormone receptors and apoptosis John Hiscott (McGill University, Canada) : Multiple Signaling Pathways Regulating the Activation of IRF-3 Paul J. Coffer (University Medical Centre, Utrecht, The Netherlands) : Forkhead transcription factors and regulation of apoptosis Martin Holcik (Molecular Genetics Laboratory, Canada) : Translational upregulation of X-linked inhibitor of apoptosis (XIAP) Oral Session 4C: Cell death and cardiovascular diseases Claudio Napoli (University of Naples, Italy; University of San Diego, California, USA) : Oxidation of LDL and apoptosis Dipak K. Das (Cardiovascular Research Centre, Farmington, USA) : to be announced Yong J. Geng (Center for Cardiovascular Biology and Atherosclerosis Research, Houston, USA) : Apoptosis in Atherosclerosis and Heart Failure Oral Session 4D : Glutathione and Apoptosis Alfonso Pompella (University of Pisa, Italy) : John T. Hancock (University of the West of England, UK) : Lina Ghibelli (Universita' di Roma, Italy) : Friday January 31, 2003 Afternoon Oral Session 5A : Apoptosis and chromatin structure Richard Pestell (Ney York, USA) : Apoptosis and histone deacetylases in hormone signaling. Piotr Widlak (Department of Experimental and Clinical, Poland) : Modeling apoptotic chromatin condensation; is it so simple ? Yoshihiro Higuchi (Department of Molecular Pharmacology, Japan) : DNA fragmentation associated with apoptosis and necrosis induced by oxidative stress Naoyuki Taniguchi (Osaka University Medical School, Japan) : An essential role for histone hypoacetylation in reactive oxygen species-induced cell proliferation arrest and apoptosis. Oral Session 5B : p53 Gerry Melino (University of Rome, Italy) : The p53 family Patrick Lee (University of Calgary, Canada) : Cell cycle and p53-mediated apoptotic response Clemens Schmitt (Max-Delbrück-Center, Germany) : Contribution of p53 and p16INK4a to the outcome of cancer therapy. Oral Session 5C : Cell death and cell cycle Eileen White (Rutgers University, New Jersey, USA) : Role of Bax and Bak mediated apoptosis in suppressing tumorigenesis Karen Vousden (National Cancer Institute, Bethesda, USA) Proliferation, cell cycle and apoptosis in cancer. Claude Prigent (CNRS - Université de Rennes, France) : The oncogene aurora-A kinase phosphorylates and inhibits proteins involved in apoptosis Kelly L. Jordan-Sciutto (University of Pennsylvania School of Dental Medicine, USA) : Altered distribution of cell cycle transcriptional regulators during Alzheimer?s disease Saturday, February 1st, 2003 Morning Oral Session 6A : Apoptosis and tissulary functions Herve Chneiweiss (College de France, Paris, France) : Keeping TNF-induced apoptosis under control in astrocytes Alberto Ortiz (Dialisis Fundacion Jimenez Diaz, Spain) : Role and regulation of apoptotic cell death in the kidney. Oral Session 6B : Cell death and blood diseases Lucia Altucci (Seconda Universita di Napoli, Italy ) : Retinoic acid-induced apoptosis in leukemia cells Tom Cotter (Dept. of Biochemistry, Cork, Ireland) : BCR-ABL in the regulation of apoptosis in chronic myeloid leukaemia Barbara Walzog (Dept. of Physiology, University of Munich, Germany) : A role for apoptosis in the control of neutrophil homoeostasis in the circulation Oral Session 6C : Cell death and neurodegenerative diseases Luc Buee (IMPRT, Lille, France) : Tau pathology and apoptosis Anne Eckert (Biozentrum, Frankfurt am Main, Germany) : Increased apoptotic cell death in sporadic and genetic Alzheimer's disease Mark S. Kindy (Department of Physiology and Neuroscience, Charleston, USA) : Stroke and apoptosis/excitosis Moussa Youdim (Eve Topf and National Parkinson Foundation; Haifa, Israel) : Rasagiline and Parkinson's disease: the essentiality of Bcl-2, PKC and proteasome activation in neuroprotection Oral Session 6D: Pharmacology of Apoptosis Caroline Dive (University of Manchester, UK) : Apoptosis and cancer chemotherapy Paul Harkin (Department of Oncology, Queen's University Belfast, N. Ireland) : Sid D. Ray (Long Island University, Brooklyn, USA) : Lessons Learned From Drug and Chemically-Induced Apoptotic Death in the Liver and Kidneys In Vivo Jacques Piette (University of Liège) : Apoptosis induced by photodynamic therapy |
||||||||||||||||
| Organized by: | Marc Diederich | |||||||||||||||
| Invited Speakers: | Stanley Korsmeyer (Harvard Medical School, Boston, USA) Michael O. Hengartner (University of Zurich) Sara C. Ahlgren (California Institute of Technology) Pierre Golstein (Centre d'Immunologie de Marseille-Luminy, France) Kate Hardy (Imperial College, London, UK) Jean-Claude Ameisen (EMI-U 9922 INSERM/Universite Paris 7, France) Guido Kroemer (Institut Gustave Roussy, France) Andreas Strasser (The Walter and Eliza Hall Institute, Victoria, Australia) Philippe Bouillet (The Walter and Eliza Hall Institute, Victoria, Australia) Jean-Claude Martinou (University of Geneva, Switzerland) Roger Davis (Worcester, Massachusetts) Helen Beere (La Jolla, USA) Jakob Troppmair (University of Wuerzburg) Thomas J. Povsic (Duke University Medical Centre, Durham, USA) Abraham Amsterdam (Weizman Institute of Science, Revohot, Israel) Hakan Billig (Department of Physiology, Goteborg, Sweden) John Peluso (University of Connecticut Health Centre, USA) Atan Gross (Department of Biological Regulation, Revohot, Israel) Bharat Aggrawal (Anderson Cancer Centre) Masataka Mori (Kumamoto University School of Medicine) Young-Joon Surh (Seoul National University) Craig Thompson (University of Pennsylvania School of Medicine) Peter H. Krammer : (German Cancer Research Centre, Heidelberg) Ulf R. Rapp (University of Wuerzburg) Rudi Beyaert (University of Ghent, Belgium) Thomas Mandrup-Poulsen (Steno Diabetes Centre, Denmark) Decio L. Eizirik (ULB, Belgium) Jurg Tschopp (University of Lausanne, Switzerland) Klaus Schulze-Osthoff (University of Münster, Germany) Seamus Martin (Trinity College, Ireland) Richard Pestell (Ney York, USA) J. Don Chen (Department of Biochemistry and Mol. Pharmacology, Worcester, MA, USA) John Hiscott (McGill University, Canada) Paul J. Coffer (University Medical Centre, Utrecht, The Netherlands) Martin Holcik (Molecular Genetics Laboratory, Canada) Claudio Napoli (University of Naples, Italy; University of San Diego, California, USA) Dipak K. Das (Cardiovascular Research Centre, Farmington, USA) Yong J. Geng (Center for Cardiovascular Biology and Atherosclerosis Research, Houston, USA) Piotr Widlak (Department of Experimental and Clinical, Poland) Yoshihiro Higuchi (Department of Molecular Pharmacology, Japan) Gerry Melino (University of Rome, Italy) Patrick Lee (University of Calgary, Canada) Clemens Schmitt (Max-Delbrück-Center, Germany) Karen Vousden (National Cancer Institute, Bethesda, USA) Claude Prigent (CNRS - Université de Rennes, France) Kelly L. Jordan-Sciutto (University of Pennsylvania School of Dental Medicine, USA) Herve Chneiweiss (College de France, Paris, France) Alberto Ortiz (Dialisis Fundacion Jimenez Diaz, Spain) Lucia Altucci (Seconda Universita di Napoli, Italy) Tom Cotter (Dept. of Biochemistry, Cork, Ireland) Barbara Walzog (Dept. of Physiology, University of Munich, Germany) Luc Buee (IMPRT, Lille, France) Anne Eckert (Biozentrum, Frankfurt am Main, Germany) Mark S. Kindy (Department of Physiology and Neuroscience, Charleston, USA) Moussa Youdim (Eve Topf and National Parkinson Foundation; Haifa, Israel) Caroline Dive (University of Manchester, UK) Paul Harkin (Department of Oncology, Queen's University Belfast, N. Ireland Ray) Sid D. Ray (Long Island University, Brooklyn, USA) |
|||||||||||||||
| Deadline for Abstracts: | 31 december 2002 | |||||||||||||||
| Registration: | CONTACT RSL, c/o M. Diederich, Centre Universitaire du Luxembourg 162A,avenue de la Faiencerie, L-1511 LUXEMBOURG, Tel : + 352 46 66 44 434 Fax : + 352 46 66 44 438 Email : meeting@cu.lu |
|||||||||||||||
| E-mail: | meeting@cu.lu | |||||||||||||||
| Posted by: | Marc Diederich | |||||||||||||||
| Host: | ggt.labext.cu.lu | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||